GSK and the British Council announced the signing of the official agreement to extend the UK-China Health and Economy Partnership.
The UK-China Health and Economy Partnership is a novel knowledge transfer initiative promoting long-term collaboration in pharmacoeconomics between leading academic institutions in China and the UK. The partnership is designed to create significant impact for Chinese patients and the economy by generating new health economics expertise.
The UK-China partnership was originally launched in Jinan, Shandong province in November 2017. With the extension of the partnership, GSK and the British Council will strengthen collaboration between UK and Chinese universities for two years from September 2018.
Science and technology are transforming the way we research diseases and improving how patients are diagnosed and treated. Rapid advances in digital technologies, especially in the field of data analytics, are enabling researchers to explore and interpret ever-larger volumes of biological data more efficiently and effectively than ever before, unlocking new scientific opportunities to develop new healthcare solutions.
This partnership aims to create a long-term, sustainable partnership in health economics, which will give UK and Chinese scholars the means to work together on world-class outcomes not possible working alone.
A total fund of £420,000 will be provided by GSK to extend the UK-China Health and Economy Partnership. In addition, Bournemouth University will provide £40,000 per year in Postgraduate Research Funding.
Liam Fox, the UK Secretary of State for International Trade, said, “I’m excited to witness the extension of the UK-China Health and Economy Partnership. I’m confident that the partnership will build important long-term collaboration between world-leading universities in the UK and China as we collectively work to advance healthcare and medical expertise”.
Carma Elliot, Director China at the British Council, said, “We are delighted to see Bournemouth University working with China to further collaboration in the field of pharmacoeconomics. This initiative is a significant contribution to the already active UK-China relationships in higher education and we are pleased that the British Council’s Partnership Challenge Fund supported its establishment, with substantial funding support coming from GSK” .
Emma Walmsley, Chief Executive Officer, GSK said, “At GSK, we believe the future of healthcare lies with the young scientists of today who will drive innovation across healthcare tomorrow. The partnership is part of our commitment to education and collaboration. Together with the British Council, we aim to enable world-leading universities in the UK and China to come together in partnership to create positive impact for Chinese patients and the economy by empowering knowledge transfer between educational institutions in both countries”.